118 related articles for article (PubMed ID: 6717896)
1. Phase I toxicologic study of Lonidamine in cancer patients.
Band PR; Deschamps M; Besner JG; Leclaire R; Gervais P; De Sanctis A
Oncology; 1984; 41 Suppl 1():56-9. PubMed ID: 6717896
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of Lonidamine in cancer patients.
Band PR; Deschamps M; Besner JG; Leclaire R; Gervais P; De Sanctis A
Oncology; 1984; 41 Suppl 1():66-8. PubMed ID: 6717898
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study.
Band PR; Maroun J; Pritchard K; Stewart D; Coppin CM; Wilson K; Eisenhauer EA
Cancer Treat Rep; 1986 Nov; 70(11):1305-10. PubMed ID: 3768873
[TBL] [Abstract][Full Text] [Related]
4. Phase II evaluation of Lonidamine in patients with advanced malignancy.
Evans WK; Shepherd FA; Mullis B
Oncology; 1984; 41 Suppl 1():69-77. PubMed ID: 6717899
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of lonidamine in inoperable non-small-cell lung cancer.
Kokron O; Maca S; Scheiner W; De Gregorio M; Ciottoli GB
Oncology; 1984; 41 Suppl 1():86-9. PubMed ID: 6717902
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of lonidamine in patients with small cell carcinoma of the lung.
Murray N; Shah A; Band P
Cancer Treat Rep; 1987 Dec; 71(12):1283-4. PubMed ID: 2825992
[TBL] [Abstract][Full Text] [Related]
7. Phase I and clinical pharmacologic evaluation of Lonidamine in patients with advanced cancer.
Young CW; Currie VE; Kim JH; O'Hehir MA; Farag FM; Kinahan JE
Oncology; 1984; 41 Suppl 1():60-5. PubMed ID: 6717897
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of lonidamine in metastatic breast cancer.
Pronzato P; Amoroso D; Bertelli G; Conte PF; Cusimano MP; Ciottoli GB; Gulisano M; Lionetto R; Rosso R
Br J Cancer; 1989 Feb; 59(2):251-3. PubMed ID: 2930690
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of lonidamine with whole body hyperthermia in advanced cancer.
Robins HI; Longo WL; Lagoni RK; Neville AJ; Hugander A; Schmitt CL; Riggs C
Cancer Res; 1988 Nov; 48(22):6587-92. PubMed ID: 3180069
[TBL] [Abstract][Full Text] [Related]
10. Chronic administration of lonidamine in untreated non-small cell lung cancer of stage III M0-1.
Scagliotti GV; Gozzelino F; Albera C; Pescetti G
Chemotherapy; 1989; 35(1):64-8. PubMed ID: 2541978
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of lonidamine in patients with metastatic renal cell carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study.
Weinerman BH; Eisenhauer EA; Besner JG; Coppin CM; Stewart D; Band PR
Cancer Treat Rep; 1986 Jun; 70(6):751-4. PubMed ID: 3524824
[TBL] [Abstract][Full Text] [Related]
12. Lonidamine in advanced colorectal cancer: a phase II study of the Italian Oncology Group for Clinical Research (GOIRC).
Passalacqua R; Bisagni G; Bertusi M; Donati D; Buzzi F; Di Costanzo F; Basurto C; Gori S
Tumori; 1989 Jun; 75(3):277-9. PubMed ID: 2672481
[TBL] [Abstract][Full Text] [Related]
13. The combined use of radiation therapy and lonidamine in the treatment of brain metastases.
DeAngelis LM; Currie VE; Kim JH; Krol G; O'Hehir MA; Farag FM; Young CW; Posner JB
J Neurooncol; 1989 Sep; 7(3):241-7. PubMed ID: 2677257
[TBL] [Abstract][Full Text] [Related]
14. Early observations on the administration of Lonidamine in cancer patients.
Barduagni A; Barduagni M; Di Lauro L; Nardi M; Gallo Curcio C; Tonachella R; Ciottoli GB; Delle Chiaie S
Oncology; 1984; 41 Suppl 1():78-81. PubMed ID: 6717900
[TBL] [Abstract][Full Text] [Related]
15. Lonidamine versus high-dose tamoxifen in progressive, advanced renal cell carcinoma: results of an ongoing randomized phase II study.
Stahl M; Schmoll E; Becker H; Schlichter A; Hoffmann L; Wagner H; Possinger K; Müller W; Köllermann M; Weidenhammer W
Semin Oncol; 1991 Apr; 18(2 Suppl 4):33-7. PubMed ID: 2031196
[TBL] [Abstract][Full Text] [Related]
16. Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors.
Di Cosimo S; Ferretti G; Papaldo P; Carlini P; Fabi A; Cognetti F
Drugs Today (Barc); 2003 Mar; 39(3):157-74. PubMed ID: 12730701
[TBL] [Abstract][Full Text] [Related]
17. A phase II clinical and pharmacokinetic study of Lonidamine in patients with advanced breast cancer.
Mansi JL; de Graeff A; Newell DR; Glaholm J; Button D; Leach MO; Payne G; Smith IE
Br J Cancer; 1991 Sep; 64(3):593-7. PubMed ID: 1911204
[TBL] [Abstract][Full Text] [Related]
18. Lonidamine alone and in combination with other chemotherapeutic agents in the treatment of cancer patients.
Pacilio G; Carteni G; Biglietto M; De Cesare M
Oncology; 1984; 41 Suppl 1():108-12. PubMed ID: 6326014
[TBL] [Abstract][Full Text] [Related]
19. Lonidamine in metastatic breast cancer.
Rosso R; Amoroso D; Gardin G; Miglietta L; Guido T; Pace M; Repetto L; Pronzato P
Semin Oncol; 1991 Apr; 18(2 Suppl 4):62-5. PubMed ID: 2031200
[TBL] [Abstract][Full Text] [Related]
20. Lonidamine in primary malignant brain tumors. Preliminary report.
Carapella CM; Iandolo B; Delle Chiaie S; Riccio A
Oncology; 1984; 41 Suppl 1():82-5. PubMed ID: 6717901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
